AKT1 and breast cancer: CircSEMA4B, a protein-coding circRNA significantly downregulated in ovarian cancer, encodes a novel protein, SEMA4B-211aa, which inhibits PIP3 production by binding to p85, thereby inhibiting AKT phosphorylation and breast cancer progression 91.